Today's NYSE & NASDAQ Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ADI Analog Devices	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tristan Gerra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$373.09	$450.00 ➝ $675.00	Outperform
AEVA Aeva Technologies	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Delaney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.29	$20.00	Neutral
ALGT Allegiant Travel	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.85	$116.00	Outperform ➝ Strong-Buy
ALKT Alkami Technology	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.38	$22.00 ➝ $25.00	Buy
ALVO Alvotech	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gerberry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.43	$7.00	Buy
AQST Aquestive Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.66	$10.00	Buy
ARE Alexandria Real Estate Equities	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wesley Golladay Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.42 -0.1%	$46.00 ➝ $52.00	Neutral
ASAN Asana	Downgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.57 -0.1%		Outperform
ASAN Asana	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Enders Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.57 -0.1%		Market Outperform
ATRC AtriCure	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marie Thibault Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.98	$45.00 ➝ $55.00	Buy
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
AXSM Axsome Therapeutics	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashwani Verma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$207.77		Buy
AXSM Axsome Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$207.77		Buy
BRCB Black Rock Coffee Bar	Reiterated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris O'Cull Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.25	$12.00 ➝ $10.00	Outperform ➝ Neutral
CLS Celestica	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Vogt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$296.03 -0.2%	$430.00	Neutral ➝ Buy
CLYM Climb Bio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.28	$20.00 ➝ $24.00	Buy
CMG Chipotle Mexican Grill	Reiterated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris O'Cull Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.84 -0.2%	$44.00 ➝ $40.00	Outperform ➝ Neutral
CRM Salesforce	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allan Verkhovski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$209.20 +0.0%	$255.00	Buy
DASH DoorDash	Downgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ross Sandler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$223.49		Equal Weight ➝ Underweight
DASH DoorDash	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Josey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$223.49		Market Outperform
DE Deere & Company	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Seiden Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$648.61 +0.2%		Overweight
DPZ Domino's Pizza	Reiterated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris O'Cull Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$341.85	$350.00	Outperform ➝ Neutral
DRI Darden Restaurants	Upgraded by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris O'Cull Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$221.81 +0.1%	$220.00 ➝ $250.00	Neutral ➝ Outperform
EAT Brinker International	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris O'Cull Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$246.06	$325.00	Outperform
ESTC Elastic	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.91 0.0%		Overweight
FBIN Fortune Brands Innovations	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$44.64 +0.2%		Equal Weight ➝ Overweight
FTDR Frontdoor	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$82.59		Outperform
GGB Gerdau	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.32 -0.2%		Neutral
HLN Haleon	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.02 +0.2%		Buy
INBX Inhibrx Biosciences	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.63	$245.00	Buy
IOND Ionic Digital	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$68.73	$85.00	Buy
IOND Ionic Digital	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$68.73	$85.00	Buy
IOT Samsara	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$39.95 +0.0%		Overweight
JANX Janux Therapeutics	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.39		Outperform
JMKE Jersey Mike's	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Margaret-May Binshtok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.80 -0.3%		Peer Perform
JMKE Jersey Mike's	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.80 -0.3%		Neutral
JMKE Jersey Mike's	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Saleh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.80 -0.3%	$28.00	Buy
JMKE Jersey Mike's	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Logan Reich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.80 -0.3%	$28.00	Outperform
JMKE Jersey Mike's	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Logan Reich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.80 -0.3%	$27.00
JMKE Jersey Mike's	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.80 -0.3%		Buy ➝ Overweight
JMKE Jersey Mike's	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.80 -0.3%		Positive
They didn't warn anyone in 1971. This time someone is warning you. (Ad) On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. Request the free guide in 30 seconds and get positioned now
JMKE Jersey Mike's	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew M. Charles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.80 -0.3%	$26.00	Buy
JMKE Jersey Mike's	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris O'Cull Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.80 -0.3%	$27.00	Outperform
JMKE Jersey Mike's	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Harbour Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.80 -0.3%	$29.00	Overweight
JMKE Jersey Mike's	Initiated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nick Setyan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.80 -0.3%	$31.00	Outperform
JMKE Jersey Mike's	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Danilo Gargiulo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.80 -0.3%	$26.00	Market Perform
JMKE Jersey Mike's	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.80 -0.3%	$27.00	Buy
JMKE Jersey Mike's	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Mullan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.80 -0.3%	$29.00	Overweight
KURA Kura Oncology	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.89		Market Outperform
KURA Kura Oncology	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.89	$24.00
KURA Kura Oncology	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.89	$24.00
LBRX LB Pharmaceuticals	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.62	$45.00 ➝ $60.00	Buy
MT ArcelorMittal	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alain Gabriel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.27 +0.1%	$82.00	Overweight
NMG Nouveau Monde Graphite	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.50 -0.3%	$4.50	Buy
NTNX Nutanix	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$67.64		Overweight
NVCT Nuvectis Pharma	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Pete Stavropoulos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.56		Overweight
NVDA NVIDIA	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$214.75 +0.0%	$350.00	Overweight
PHM PulteGroup	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$129.00		Peer Perform ➝ Outperform
QTTB Q32 Bio	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Judah Frommer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.97	$34.00	Overweight
RBRK Rubrik	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$99.82 -0.3%		Buy
RDDT Reddit	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$153.05 -0.2%		Market Outperform
REF Reformation	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Straton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.50 +0.1%	$16.00	Equal Weight
REF Reformation	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Altschwager Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.50 +0.1%	$19.00	Outperform
REF Reformation	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.50 +0.1%		Outperform
REF Reformation	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Irene Nattel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.50 +0.1%	$18.00	Outperform
REF Reformation	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Janine Stichter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.50 +0.1%	$20.00	Buy
RIO Rio Tinto	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alain Gabriel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$105.33 +0.0%	$90.00	Underweight
S SentinelOne	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Gallo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.20 +0.0%		Buy
SIG Signet Jewelers	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mauricio Serna Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.36 0.0%	$122.00	Buy
SUZ Suzano	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.77 -0.1%	$13.00	Neutral ➝ Buy
TSLA Tesla	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$362.86		Market Perform
UI Ubiquiti	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$557.14 -0.3%	$489.00	Underweight
VEEV Veeva Systems	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$248.26 +0.1%	$270.00	Buy
WEAV Weave Communications	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.30 +0.1%		Outperform ➝ Market Perform
XRAY DENTSPLY SIRONA	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Glen Santangelo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.92	$11.00	Underweight
ZM Zoom Communications	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allan Verkhovski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.43	$125.00	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 08:00 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NYSE and NASDAQ Stock Price Targets and Analyst Ratings

Frequently Asked Questions